CLX - The Clorox Company

NYSE - NYSE Delayed Price. Currency in USD
155.09
+0.87 (+0.56%)
At close: 4:02PM EDT

155.09 0.00 (0.00%)
After hours: 5:15PM EDT

Stock chart is not supported by your current browser
Previous Close154.22
Open153.59
Bid154.84 x 2200
Ask154.86 x 800
Day's Range153.12 - 155.66
52 Week Range115.00 - 167.70
Volume911,506
Avg. Volume950,901
Market Cap19.877B
Beta (3Y Monthly)0.47
PE Ratio (TTM)25.63
EPS (TTM)6.05
Earnings DateMay 1, 2019
Forward Dividend & Yield3.84 (2.39%)
Ex-Dividend Date2019-04-23
1y Target Est153.00
Trade prices are not sourced from all markets
  • Clorox Stock: Valuation and Wall Street Ratings
    Market Realist4 hours ago

    Clorox Stock: Valuation and Wall Street Ratings

    Clorox: What to Expect from Q3 Earnings(Continued from Prior Part)Valuation summary Clorox’s (CLX) sustained momentum in sales and margin expansion has impressed. However, an expected slowdown in sales and pressure on earnings from higher costs

  • Will Clorox’s Bottom Line Return to the Growth Path in Q3?
    Market Realist4 hours ago

    Will Clorox’s Bottom Line Return to the Growth Path in Q3?

    Clorox: What to Expect from Q3 Earnings(Continued from Prior Part)Consensus estimate Clorox (CLX) posted better-than-expected earnings during its last reported quarter. However, its EPS fell 21% on a year-over-year basis as the previous year’s

  • Why Clorox Is Likely to Keep Up Its Sales Momentum
    Market Realist4 hours ago

    Why Clorox Is Likely to Keep Up Its Sales Momentum

    Clorox: What to Expect from Q3 Earnings(Continued from Prior Part)Analysts’ estimate Analysts expect Clorox (CLX) to post revenues of $1.6 billion in the third quarter of fiscal 2019, which represents year-over-year growth of 3.4%. Its Nutranext

  • Why Clorox Stock Is Underperforming Peers
    Market Realist4 hours ago

    Why Clorox Stock Is Underperforming Peers

    Clorox: What to Expect from Q3 EarningsStock performance Clorox (CLX) stock was trading flat on a year-to-date basis as of April 24, and it has underperformed the broader markets as well as its peers. In comparison, the S&P 500 Index has grown

  • Procter & Gamble’s Valuation and Analysts’ Rating
    Market Realist12 hours ago

    Procter & Gamble’s Valuation and Analysts’ Rating

    Procter & Gamble Stock Fell despite Strong Q3 Results(Continued from Prior Part)Valuation  Procter & Gamble’s (PG) impressive organic sales, productivity savings, and lower effective tax rate supported its stock. Procter & Gamble

  • Analyzing Procter & Gamble’s Q3 Earnings Beat
    Market Realistyesterday

    Analyzing Procter & Gamble’s Q3 Earnings Beat

    Procter & Gamble Stock Fell despite Strong Q3 Results(Continued from Prior Part)History of beating estimates Procter & Gamble (PG) continued to beat analysts’ bottom-line estimate. Including the EPS beat in the third quarter, Procter &

  • Can Clorox (CLX) Keep the Earnings Beat Streak Alive in Q3?
    Zacksyesterday

    Can Clorox (CLX) Keep the Earnings Beat Streak Alive in Q3?

    Clorox (CLX) gains from smooth progress on its 2020 Strategy, focus on e-commerce growth and brand-management initiatives.

  • Clorox (CLX) Earnings Expected to Grow: Should You Buy?
    Zacksyesterday

    Clorox (CLX) Earnings Expected to Grow: Should You Buy?

    Clorox (CLX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • Procter & Gamble Posted Strong Sales in Q3
    Market Realistyesterday

    Procter & Gamble Posted Strong Sales in Q3

    Procter & Gamble Stock Fell despite Strong Q3 Results(Continued from Prior Part)Strong organic sales  Procter & Gamble (PG) posted better-than-expected third-quarter sales. Procter & Gamble’s net sales of $16.5 billion beat

  • UL or CLX: Which Is the Better Value Stock Right Now?
    Zacksyesterday

    UL or CLX: Which Is the Better Value Stock Right Now?

    UL vs. CLX: Which Stock Is the Better Value Option?

  • How Analysts Reacted to KMB’s First-Quarter Results
    Market Realistyesterday

    How Analysts Reacted to KMB’s First-Quarter Results

    Key Takeaways from Kimberly-Clark’s First Quarter(Continued from Prior Part)Analysts raised target price Several analysts increased their price target on Kimberly-Clark (KMB) stock after the company’s better-than-expected first-quarter

  • PR Newswire2 days ago

    Rainbow Light and Vitamin Angels Celebrate 25 years of Helping Women and Children in Need with Vitamin Drops in 25 U.S. Communities

    Vitamin Angels® (www.vitaminangels.org), is a global public health organization that distributes life-saving vitamins to at-risk women and children in the U.S. and around the world. Jaime King, a staunch supporter of women's health, will attend the initial celebration on April 30th at Claris Health, a clinic that provides life-changing medical, mental health and support services to women, men and families, in Inglewood, CA.

  • Procter & Gamble Beats Third-Quarter Estimates
    Market Realist2 days ago

    Procter & Gamble Beats Third-Quarter Estimates

    Procter & Gamble Beats Third-Quarter EstimatesKey takeaways Procter & Gamble (PG) posted stronger-than-expected third-quarter results on Tuesday, April 23. Robust organic sales, a lower effective tax rate, and share buybacks helped Procter

  • What Drove Kimberly-Clark’s Q1 Earnings?
    Market Realist2 days ago

    What Drove Kimberly-Clark’s Q1 Earnings?

    Key Takeaways from Kimberly-Clark’s First Quarter(Continued from Prior Part)EPS exceeds expectations Kimberly-Clark (KMB) posted better-than-expected earnings in the first quarter of 2019. Kimberly-Clark’s adjusted earnings of $1.66 per share

  • Kimberly-Clark Stock Rose on Stronger-Than-Expected Q1 Results
    Market Realist2 days ago

    Kimberly-Clark Stock Rose on Stronger-Than-Expected Q1 Results

    Key Takeaways from Kimberly-Clark’s First QuarterKey takeawaysKimberly-Clark (KMB) stock rose 5.4% on Monday, April 22, after the company released stronger-than-expected first-quarter results. Higher pricing and a favorable mix helped

  • Why Colgate-Palmolive’s EPS Could Mark a Double-Digit Fall
    Market Realist3 days ago

    Why Colgate-Palmolive’s EPS Could Mark a Double-Digit Fall

    Persisting Challenges Could Hurt Colgate-Palmolive in Q1(Continued from Prior Part)Consensus estimateColgate-Palmolive’s (CL) bottom line has stayed low and registered YoY (year-over-year) falls for the past two consecutive quarters despite a

  • Why Colgate-Palmolive’s Q1 Sales Could Continue to Fall
    Market Realist3 days ago

    Why Colgate-Palmolive’s Q1 Sales Could Continue to Fall

    Persisting Challenges Could Hurt Colgate-Palmolive in Q1(Continued from Prior Part)The consensus estimate for the first quarterColgate-Palmolive (CL) has failed to impress with its sales performance in the past several quarters. The company managed

  • What to Expect from Kimberly-Clark Stock
    Market Realist3 days ago

    What to Expect from Kimberly-Clark Stock

    Kimberly-Clark Beats Q1 Estimates on Higher Pricing(Continued from Prior Part)Challenges persist Kimberly-Clark (KMB) stock could benefit from its stronger-than-expected first-quarter results in the near term. Higher pricing, a favorable mix, and

  • Persisting Challenges Could Hurt Colgate-Palmolive in Q1
    Market Realist3 days ago

    Persisting Challenges Could Hurt Colgate-Palmolive in Q1

    Persisting Challenges Could Hurt Colgate-Palmolive in Q1What to expect Colgate-Palmolive (CL) is scheduled to announce its first-quarter earnings results before the market opens on April 26. Analysts’ first-quarter estimates indicate that

  • 3 Stocks to Buy and Hold for the Next 50 Years
    Motley Fool5 days ago

    3 Stocks to Buy and Hold for the Next 50 Years

    These three companies are built for long-term performance.

  • Now Is the Right Time to Buy Kraft Heinz Stock
    InvestorPlace7 days ago

    Now Is the Right Time to Buy Kraft Heinz Stock

    Kraft Heinz (NYSE:KHC) CEO Bernardo Hees, who gained notoriety on Wall Street as a cost-cutter, will now have to figure out how to invest money into the beleaguered packaged food company if its long-suffering shareholders ever hope to get any relief.Source: Mike Mozart via FlickrUnfortunately, Hees won't be able to just write a check to make KHC's problems go away. Like other packaged food companies, KHC has been hurt by the rising consumer demand for "fresh and healthy" ingredients at the expense of processed food. New York-based KHC made matters worse by making unrealistic forecasts for the savings of its 2015 merger, which loaded its balance sheet with more than $31 billion in debt. Plunging Share PriceKHC stock has plunged more than 64% since Unilever (NYSE:UL) rejected the company's unsolicited $143 billion offer. The stock was further bloodied by its recent announcement of disappointing earnings, a $15 billion write-down, a dividend cut and an SEC investigation into its accounting practices. S&P recently announced that it was reviewing KHC's debt for a possible downgrade after the company missed the deadline to file its annual report (form 10-K) with the Securities & Exchange Commission. InvestorPlace - Stock Market News, Stock Advice & Trading TipsDuring the company's earnings conference call, Hees tried to reassure investors that he was willing to deploy capital where it's needed. Hees is also is a partner with 3G Capital, the Brazilian private equity that owned Heinz and arranged with Warren Buffett for the merger with Kraft. * 6 Cheap Stocks That Cost Less Than $10 "In a nutshell, we plan to go to market in 2019 with a stronger innovation pipeline than we ever had, backed by more marketing dollars while leveraging advantaged category managed and go-to-market initiatives to win assortment and improve distribution across all channels, including e-commerce," He said. "And we plan to do this while we maintain industry-leading margins."Easier said than done since KHC clearly fired too many workers and damaged its brands, damage which won't be easy or cheap to fix.The company is trying to clean up the mess Hees helped create. According to media reports, Kraft Heinz is reviewing strategic options for its Maxwell House Coffee business including a possible sale and may dispose of other well-known brands such as Breakstone's Cottage Cheese and sour cream. Selling off poorly performing businesses is a step in the right direction though it isn't a substitute for a business strategy. The Oracle of OmahaIndeed, the growth through acquisitions approach isn't the answer for KHC. According to CNBC, the company passed on bidding for Pinnacle Foods and failed to make a compelling offer for Campbell Soup when it was being shopped around last year. KHC stock deserves to be in Wall Street's penalty box but it's not going to be in their forever. The company has a major fan in Buffett, who recently described the company as a "fabulous" business though he admitted that Berkshire Hathaway (NYSE:BRK.A, NYSE:BRK.B) "overpaid" for Kraft. He has no plans to liquidate his position.For investors with a large tolerance for risk, KHC is worth testing Buffett's maxim to "be fearful when others are greedy and to be greedy only when others are fearful." However, there are better places for investors to put their money in the consumer sector, including Campbell, Chuch & Dwight (NYSE:CHL) and Clorox (NYSE:CLX).As of this writing, Jonathan Berr did not hold a position in any of the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 5 Dividend Stocks Perfect for Retirees * 7 Reasons the Stock Market Rally Isn't Over Yet * 10 S&P 500 Stocks to Weather the Earnings Storm Compare Brokers The post Now Is the Right Time to Buy Kraft Heinz Stock appeared first on InvestorPlace.

  • Going Into Earnings, Will Procter & Gamble Stock Move Higher?
    InvestorPlace7 days ago

    Going Into Earnings, Will Procter & Gamble Stock Move Higher?

    Procter & Gamble (NYSE:PG) will announce its earnings next Tuesday before the opening bell. Despite the venerable personal-care products maker's reputation as a defensive dividend payer, PG stock has rallied massively over the last year.Source: Mike Mozart via Flickr (Modified)Unfortunately, the rally may have left new investors with less incentive to buy PG stock. With the multiples of PG stock having risen to multi-year highs and its profit growth remaining moderate at best, investors should probably think twice about buying Procter and Gamble at these levels. * 5 Dividend Stocks Perfect for Retirees Expect Slight Earnings, Revenue IncreasesFor PG's fiscal third quarter, analysts' consensus earnings per share estimate is $1.03. That's 3% higher than Q3 of 2018 when the company earned $1 per share of PG stock. Analysts on average predict revenues of $16.32 billion, a slight gain from the $16.28 billion the company generated during last year's Q3.InvestorPlace - Stock Market News, Stock Advice & Trading TipsOn the surface, PG appears to be performing well. Trading near its all-time highs, PG stock is 50% above its levels of one year ago. That seems unusual for a stock that traders tend to buy for its dividend.After the company raised the dividend of PG stock this year, the payout has risen for 63 straight years, the fourth-longest streak on Wall Street. PG has paid a dividend every year since 1890. Currently at $2.87 per share, the payout yields 2.75%. Will Investors Continue to Buy PG Stock After the Surge?The impressive rally of PG stock has made it less appealing. The dividend yield of PG stock was about 3.5% this time last year, versus 2.75% now. Moreover, PG's price-earnings (PE) ratio has risen to 25.74. In fairness, Procter & Gamble's peers such as Colgate-Palmolive (NYSE:CL), Kimberly Clark (NYSE:KMB), and Clorox (NYSE:CLX) trade at comparable or higher multiples.Still, the current PE ratio of PG is above its average PE over the last five years of 23.5. It's also well above the mid-teen multiples Procter & Gamble was awarded in the early part of the decade. Also, Wall Street expects PG to report solid, but unimpressive, profit increases. On average, analysts forecast 5.2% profit growth for this fiscal year and 7% next year. Those increases appear too low to justify the current PE ratio of PG stock.Furthermore, even after spinning off numerous brands in the middle part of the decade, PG stock remains vulnerable. For all of its accolades, the competitive moat of Procter and Gamble begins and ends with brand recognition and store-shelf space. Consumers know and love PG's brands such as Tide laundry detergent and Bounty paper towels. However, thanks to e-commerce, consumers can more easily find comparable products at lower prices.I do not think the increased competition will wipe out PG stock. I also do not believe that the rising dividend of PG stock will be threatened. Still, the company may have difficulty growing its revenue, making PG's current valuation difficult to justify. Going into earnings, few investors have an incentive to buy Procter and Gamble at these levels. Final Thoughts on PG StockGiven the recent increases in its price, PG stock will probably struggle to move higher in the near-term. As a result, I see no reason to buy PG 's shares ahead of its earnings.Procter and Gamble enjoyed an unexpected but impressive run over the last year. However, consumer defensive stocks better known for paying dividends rarely have such rallies. Despite increasing competition and analysts' belief that the company's revenue growth was anemic last quarter, I think the stock's dividend will continue to rise. However, other stocks feature annual dividend hikes and lower valuations.For now, income-oriented investors will probably find higher overall returns elsewhere.As of this writing, Will Healy did not hold a position in any of the aforementioned stocks. You can follow Will on Twitter at @HealyWriting. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 5 Dividend Stocks Perfect for Retirees * 7 Reasons the Stock Market Rally Isn't Over Yet * 10 S&P 500 Stocks to Weather the Earnings Storm Compare Brokers The post Going Into Earnings, Will Procter & Gamble Stock Move Higher? appeared first on InvestorPlace.

  • What Analysts Suggest for PG Stock ahead of Its Q3 Results
    Market Realist7 days ago

    What Analysts Suggest for PG Stock ahead of Its Q3 Results

    What to Expect from Procter & Gamble’s Q3 2019 Results(Continued from Prior Part)Consensus target price indicates downsideThe majority of analysts continue to suggest “holds” on Procter & Gamble (PG) stock. The company has impressed

  • Will Procter & Gamble Beat Analysts’ EPS Estimate in Q3 2019?
    Market Realist8 days ago

    Will Procter & Gamble Beat Analysts’ EPS Estimate in Q3 2019?

    What to Expect from Procter & Gamble’s Q3 2019 Results(Continued from Prior Part)Positive surprise history Procter & Gamble (PG) has a long history of exceeding analysts’ EPS estimates. The company has surpassed Wall Street’s EPS

  • What to Expect from Procter & Gamble’s Q3 2019 Results
    Market Realist8 days ago

    What to Expect from Procter & Gamble’s Q3 2019 Results

    What to Expect from Procter & Gamble’s Q3 2019 ResultsPG is expected to sustain momentum Procter & Gamble (PG) is scheduled to announce its earnings results for the third quarter of fiscal 2019 before the market opens on April 23.